Trevi Therapeutics Inc.(TRVI)
盘后10.510.03+0.29%18:00 EST
10.48-0.28-2.60%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Trevi Therapeutics Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Trevi Therapeutics, Inc.于2011年3月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化纳布啡ER，以治疗严重的神经介导的疾病。该公司目前正在开发纳布啡ER，用于治疗患有特发性肺纤维化或IPF的慢性瘙痒，慢性咳嗽，以及帕金森病患者的左旋多巴诱导的运动障碍或LID。这些病症具有共同的病理生理学，其通过中枢和外周神经系统中的阿片受体介导。由于纳布啡作为阿片受体调节剂的作用机制，该公司认为这有可能有效治疗这些疾病。- 2025-12-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-07Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-10-03Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-27Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-07Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-07Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-07Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-06-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-04Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-02Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-02Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-09Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
10.93
今开
10.80
量比
1.03
最低
10.46
昨收
10.76
换手率
1.19%